Two years after its first approval for an ultra-rare lipid disorder, #Ionis' #Tryngolza has been approved by the #FDA for #severehypertriglyceridaemia (sHTG), a much larger patient population.
pharmaphorum.com/news/ionis-t...
pharmaphorum.com/news/ionis-t...
Ionis' Tryngolza claims critical label expansion in US
Ionis' Tryngolza has been approved for severe hypertriglyceridaemia, opening the door to what the company thinks could be a $3bn market opportunity.
pharmaphorum.com
June 25, 2026 at 10:08 AM
Two years after its first approval for an ultra-rare lipid disorder, #Ionis' #Tryngolza has been approved by the #FDA for #severehypertriglyceridaemia (sHTG), a much larger patient population.
pharmaphorum.com/news/ionis-t...
pharmaphorum.com/news/ionis-t...